RECURSION PHARMACEUTICALS-A (RXRX) Institutional Shareholders

RECURSION PHARMACEUTICALS-A (RXRX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $1.02B in RXRX holdings during the latest filing period.

Blackrock, Inc. is currently the largest disclosed institutional shareholder of RXRX tracked by InsiderSet, reporting ownership valued at approximately $132.60M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $129.58M, representing an estimated loss of -2.28% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 67% of the total disclosed RXRX value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., ARK Invest, State Street Corp, and several other long-term asset managers with concentrated positions in RECURSION PHARMACEUTICALS-A (RXRX).

This page ranks the largest institutional RXRX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

334

Total Reported Value

$1.02B

Largest Holder

Blackrock, Inc.

Largest Position

$132.60M

Insider Transactions (90d)

17

Latest Filing Quarter

Q2 2026

New Institutional Positions

59

Funds Exiting Positions

0

Page 1 of 7
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Blackrock, Inc.0.00%43,192,306$132,600,379$129,576,918-$3,023,461-2.28%
ARK InvestCathie Wood0.96%40,212,769$123,453,202$120,638,307-$2,814,895-2.28%
State Street Corp0.00%28,490,638$87,466,259$85,471,914-$1,994,345-2.28%
Baillie Gifford & Co0.07%23,675,407$72,683,499$71,026,221-$1,657,278-2.28%
Vanguard Portfolio Management Llc0.00%22,759,100$69,870,437$68,277,300-$1,593,137-2.28%
Vanguard Capital Management Llc0.00%22,244,387$68,290,268$66,733,161-$1,557,107-2.28%
Softbank Group Corp.0.37%13,636,515$41,864,101$40,909,545-$954,556-2.28%
Geode Capital Management, Llc0.00%12,275,084$37,692,773$36,825,252-$867,521-2.30%
Mic Capital Management Uk Llp8.40%9,644,032$29,607,180$28,932,096-$675,084-2.28%
Sumitomo Mitsui Trust Group, Inc.0.01%5,511,687$20,227,891$16,535,061-$3,692,830-18.26%
Goldman Sachs Group Inc0.00%6,065,661$18,621,579$18,196,983-$424,596-2.28%
Data Collective Iv Gp, Llc32.60%5,941,120$18,239,238$17,823,360-$415,878-2.28%
Amova Asset Management Americas, Inc.0.23%5,419,221$16,582,816$16,257,663-$325,153-1.96%
Ubs Group Ag0.00%5,101,237$15,660,798$15,303,711-$357,087-2.28%
Susquehanna International Group, Llp0.02%4,225,277$12,971,600$12,675,831-$295,769-2.28%
Two Sigma Investments, Lp0.01%4,066,315$12,483,587$12,198,945-$284,642-2.28%
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc0.00%4,023,398$12,351,832$12,070,194-$281,638-2.28%
Northern Trust Corp0.00%3,968,411$12,183,022$11,905,233-$277,789-2.28%
Dcvc Opportunity Fund Ii Gp, Llc87.48%3,951,141$12,130,003$11,853,423-$276,580-2.28%
Charles Schwab Investment Management Inc0.00%3,808,798$11,693,010$11,426,394-$266,616-2.28%
Vanguard Fiduciary Trust Co0.00%3,514,983$10,790,998$10,544,949-$246,049-2.28%
Iq Eq Fund Management (Ireland) Ltd0.61%2,604,317$9,557,843$7,812,951-$1,744,892-18.26%
Marshall Wace, Llp0.01%2,876,928$8,832,169$8,630,784-$201,385-2.28%
Lingotto Investment Management Llp0.17%2,206,661$8,098,446$6,619,983-$1,478,463-18.26%
Millennium Management Llc0.01%2,612,277$8,019,690$7,836,831-$182,859-2.28%
First Trust Advisors Lp0.01%2,610,726$8,014,928$7,832,178-$182,750-2.28%
Bank Of America Corp0.00%2,496,831$7,665,272$7,490,493-$174,779-2.28%
Renaissance Technologies LLCJim Simons0.01%2,400,605$7,369,857$7,201,815-$168,042-2.28%
Morgan Stanley0.00%2,185,329$6,708,961$6,555,987-$152,974-2.28%
Capital Fund Management S.A.0.05%1,909,480$5,862,103$5,728,440-$133,663-2.28%
Bank Of New York Mellon Corp0.00%1,462,631$4,490,277$4,387,893-$102,384-2.28%
Man Group Plc0.01%1,199,563$3,682,659$3,598,689-$83,970-2.28%
Nuveen, Llc0.00%1,164,603$3,575,331$3,493,809-$81,522-2.28%
Comprehensive Financial Management Llc0.10%941,895$2,891,618$2,825,685-$65,933-2.28%
Mitsubishi Ufj Trust & Banking Corp0.01%908,455$2,788,957$2,725,365-$63,592-2.28%
Group One Trading Llc0.09%901,111$2,766,411$2,703,333-$63,078-2.28%
Rafferty Asset Management, Llc0.01%890,595$2,734,127$2,671,785-$62,342-2.28%
Jump Financial, Llc0.04%889,933$2,732,094$2,669,799-$62,295-2.28%
Swiss National Bank0.00%877,000$2,692,390$2,631,000-$61,390-2.28%
Bnp Paribas Asset Management Holding S.A.0.00%790,971$2,428,280$2,372,913-$55,367-2.28%
Stifel Financial Corp0.00%776,928$2,385,190$2,330,784-$54,406-2.28%
Fmr Llc0.00%736,654$2,261,527$2,209,962-$51,565-2.28%
Vestmark Advisory Solutions, Inc.0.02%726,986$2,231,847$2,180,958-$50,889-2.28%
Invesco Ltd.0.00%691,153$2,121,840$2,073,459-$48,381-2.28%
Citadel Advisors Llc0.00%624,659$1,917,703$1,873,977-$43,726-2.28%
Alliancebernstein L.P.0.00%457,504$1,871,191$1,372,512-$498,679-26.65%
Rhumbline Advisers0.00%603,759$1,853,522$1,811,277-$42,245-2.28%
Pivotal Bioventure Partners Investment Advisor Llc0.65%595,518$1,828,240$1,786,554-$41,686-2.28%
Nan Fung Group Holdings Ltd1.51%595,287$1,827,531$1,785,861-$41,670-2.28%
California State Teachers Retirement System0.00%574,637$1,764,136$1,723,911-$40,225-2.28%

Frequently asked questions about RXRX

  • Who owns the most RXRX stock?

    The largest holders of RXRX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for RECURSION PHARMACEUTICALS-A (RXRX).

  • Is RXRX widely held by superinvestors?

    Many widely followed stocks like RXRX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly RXRX is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.